• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Correction: combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Correction....pdf
    Size:
    378.9Kb
    Format:
    PDF
    Description:
    Found with Open Access Button
    Download
    Authors
    Zanjirband, M.
    Curtin, N.
    Edmondson, Richard J
    Lunec, J.
    Affiliation
    Faculty Institute for Cancer Sciences, University of Manchester, Manchester M13 9WL, United Kingdom.
    Issue Date
    2024
    
    Metadata
    Show full item record
    Citation
    Zanjirband M, Curtin N, Edmondson RJ, Lunec J. Correction: Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer. Oncotarget. 2024 Feb 22;15:142. PubMed PMID: 38386812. Pubmed Central PMCID: PMC10883681. Epub 2024/02/22. eng.
    Journal
    Oncotarget
    URI
    http://hdl.handle.net/10541/626989
    DOI
    10.18632/oncotarget.28523
    PubMed ID
    38386812
    Additional Links
    https://dx.doi.org/10.18632/oncotarget.28523
    Type
    Other
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.18632/oncotarget.28523
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer.
    • Authors: Zanjirband M, Curtin N, Edmondson RJ, Lunec J
    • Issue date: 2017 Sep 19
    • Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents and in combined treatment with cisplatin in ovarian cancer.
    • Authors: Zanjirband M, Edmondson RJ, Lunec J
    • Issue date: 2016 Jun 28
    • MDM2 antagonists as a novel treatment option for acute myeloid leukemia: perspectives on the therapeutic potential of idasanutlin (RG7388).
    • Authors: Khurana A, Shafer DA
    • Issue date: 2019
    • Co-delivery of p53 and MDM2 inhibitor RG7388 using a hydroxyl terminal PAMAM dendrimer derivative for synergistic cancer therapy.
    • Authors: Chen K, Xin X, Qiu L, Li W, Guan G, Li G, Qiao M, Zhao X, Hu H, Chen D
    • Issue date: 2019 Dec
    • ATM Dependent DUSP6 Modulation of p53 Involved in Synergistic Targeting of MAPK and p53 Pathways with Trametinib and MDM2 Inhibitors in Cutaneous Melanoma.
    • Authors: Wu CE, Koay TS, Esfandiari A, Ho YH, Lovat P, Lunec J
    • Issue date: 2018 Dec 20
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.